Skip to content
DefDex

Federal award

SIEMENS HEALTHCARE DIAGNOSTICS INC.

W81K0023P0188

Contract

Obligated and Ceiling

Obligated (net)
$103,304.87
Ceiling (potential value, not spending)
$175,474.25
Current value
$139,389.56
Gross positive obligations
$103,304.87

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ALTAIR ENGINEERING INC. · XEAUKVYXD3W1
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0023P0188
Award type code
B
Actions
7 · Jul 24, 2023 to May 13, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History7

Award actions
DateFYModAction typeObligationCompany in company totals
May 13, 2026FY2026P00006G$0.00
—
Dec 3, 2025FY2026P00005C$36,084.69
—
Aug 19, 2025FY2025P00004G$0.00
—
Dec 12, 2024FY2025P00003C$36,084.69
—
May 8, 2024FY2024P00002G$0.00
—
Dec 27, 2023FY2024P00001C$31,135.49
—
Jul 24, 2023FY20230—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.